U.S. Pharmaceuticals & Biotech High Return On Equity, Low Debt

Merck

Market Cap: US$199.2b

Operates as a healthcare company worldwide.

Waters

Market Cap: US$19.3b

Provides analytical workflow solutions in Asia, the Americas, and Europe.

Medpace Holdings

Market Cap: US$9.1b

Provides clinical research-based drug and medical device development services in North America, Europe, and Asia.

Protagonist Therapeutics

Market Cap: US$2.6b

A biopharmaceutical company, develops peptide therapeutics for hematology and blood disorders, and inflammatory and immunomodulatory diseases.

ACADIA Pharmaceuticals

Market Cap: US$2.4b

A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.

Agios Pharmaceuticals

Market Cap: US$1.5b

A biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States.

Puma Biotechnology

Market Cap: US$139.9m

A biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally.

China SXT Pharmaceuticals

Market Cap: US$34.3m

A pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China.

Scinai Immunotherapeutics

Market Cap: US$1.7m

A development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious and autoimmune diseases in Israel.